Pneumonia vaccine study for hospitalized adults 65 and older
Part of Infections, Lungs & breathing clinical trials.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 65 or older
- You are currently hospitalized with suspected pneumonia (CAP) that fits several symptoms
- You have pneumonia-confirming imaging results (chest X-ray or scan showing signs of pneumonia)
- You can sign an informed consent form (or your legal helper can, if allowed)
- You did not get a pneumococcal vaccine in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to diagnose pneumonia faster and more accurately in older adults who come to the emergency room with breathing problems. The goal is to see if these new tests work better than the current methods.
This study is looking at adults with pneumonia to better understand how severe the infection is and how it may affect recovery. By joining, you will help doctors learn more about predicting outcomes for people with similar conditions.
This study looks at medical records from adults who have pneumonia with a confirmed germ, to better understand how the disease develops and how people recover. It may help guide future care decisions.
This study looks at a urine test for pneumonia in children aged 12 to 24 months. It aims to see if the test can help diagnose pneumonia better, especially in those with symptoms like fever, cough, and fast breathing.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.